F J Ortiz de Frutos1, A Torrelo2, R de Lucas3, M A González4, A Alomar5, Á Vera6, S Ros7, A M Mora8, J Cuervo9. 1. Hospital Universitario 12 de Octubre, Madrid, España. 2. Hospital Infantil Universitario Niño Jesús, Madrid, España. 3. Hospital Universitario La Paz, Madrid, España. 4. Hospital Sant Joan de Deu, Barcelona, España. 5. Institut Universitari Dexeus, Barcelona, España. 6. Complejo Hospitalario Carlos Haya, Málaga, España. 7. Hospital de la Santa Creu i Sant Pau, Barcelona, España. 8. Departamento Médico de Astellas Pharma, Madrid, España. 9. LA-SER Outcomes, Oviedo, España. Electronic address: javierortiz@aedv.es.
Abstract
INTRODUCTION AND OBJECTIVES: To analyze the triggers of atopic dermatitis (AD), adherence to medical recommendations, disease control, and health-related quality of life (HRQOL) from the patient's perspective. PATIENTS AND METHODS: This was a multicenter, cross-sectional, epidemiological study with the participation of adults (age >16 years; n=125) and children (age, 2-15 years, n=116). Patients had a history of at least 12 months of moderate to severe AD with a moderate to severe flare (Investigator Global Assessment score>2) at the time of recruitment. The Mann-Whitney U test was used to evaluate relationships between disease severity, determined according to the Scoring in Atopic Dermatitis index, and triggers reported by patients, adherence to recommendations and pharmacological therapy, HRQOL, and patient-perceived control. RESULTS: The most common triggers were cosmetic products, clothing, mites, detergents/soaps, and changes in temperature. In 47.2% of adults and 39.7% of children, pharmacological therapy was not initiated at flare onset. Adherence was highest to pharmacological therapy, skin moisturizing, and medical care recommendations. Disease control was considered insufficient by 41.6% of adults and 27. 6% of pediatric patients and, in adults, this was associated with the severity of AD (P=.014). CONCLUSIONS: The therapeutic control of AD is susceptible to improvement, especially in adults. Although patients state that they follow medical recommendations, a significant percentage of patients do not apply recommended treatments correctly. Better education about the disease and its management would appear to be necessary to improve disease control and HRQOL.
INTRODUCTION AND OBJECTIVES: To analyze the triggers of atopic dermatitis (AD), adherence to medical recommendations, disease control, and health-related quality of life (HRQOL) from the patient's perspective. PATIENTS AND METHODS: This was a multicenter, cross-sectional, epidemiological study with the participation of adults (age >16 years; n=125) and children (age, 2-15 years, n=116). Patients had a history of at least 12 months of moderate to severe AD with a moderate to severe flare (Investigator Global Assessment score>2) at the time of recruitment. The Mann-Whitney U test was used to evaluate relationships between disease severity, determined according to the Scoring in Atopic Dermatitis index, and triggers reported by patients, adherence to recommendations and pharmacological therapy, HRQOL, and patient-perceived control. RESULTS: The most common triggers were cosmetic products, clothing, mites, detergents/soaps, and changes in temperature. In 47.2% of adults and 39.7% of children, pharmacological therapy was not initiated at flare onset. Adherence was highest to pharmacological therapy, skin moisturizing, and medical care recommendations. Disease control was considered insufficient by 41.6% of adults and 27. 6% of pediatric patients and, in adults, this was associated with the severity of AD (P=.014). CONCLUSIONS: The therapeutic control of AD is susceptible to improvement, especially in adults. Although patients state that they follow medical recommendations, a significant percentage of patients do not apply recommended treatments correctly. Better education about the disease and its management would appear to be necessary to improve disease control and HRQOL.
Keywords:
Atopic dermatitis; Calidad de vida; Control de la enfermedad; Cumplimiento del paciente; Dermatitis atópica; Desencadenante; Disease control; Patient adherence; Quality of life; Trigger
Authors: Sara Alcantara-Luna; Ricardo Ruiz-Villaverde; Javier Domínguez-Cruz; Manuel Galán-Gutiérrez; Francisco Navarro-Triviño; Jose-Juan Pereyra-Rodriguez; Jose-Carlos Armario-Hita Journal: Int J Environ Res Public Health Date: 2022-08-29 Impact factor: 4.614
Authors: Andrea Montes-Torres; Mar Llamas-Velasco; Alejandra Pérez-Plaza; Guillermo Solano-López; Javier Sánchez-Pérez Journal: J Clin Med Date: 2015-04-03 Impact factor: 4.241